Literature DB >> 21868382

Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses.

Joost P Uittenbogaard1, Bert Zomer, Peter Hoogerhout, Bernard Metz.   

Abstract

β-Propiolactone is often applied for inactivation of viruses and preparation of viral vaccines. However, the exact nature of the reactions of β-propiolactone with viral components is largely unknown. The purpose of the current study was to elucidate the chemical modifications occurring on nucleotides and amino acid residues caused by β-propiolactone. Therefore, a set of nucleobase analogues was treated with β-propiolactone, and reaction products were identified and quantified. NMR revealed at least one modification in either deoxyguanosine, deoxyadenosine, or cytidine after treatment with β-propiolactone. However, no reaction products were found from thymidine and uracil. The most reactive sides of the nucleobase analogues and nucleosides were identified by NMR. Furthermore, a series of synthetic peptides was used to determine the conversion of reactive amino acid residues by liquid chromatography-mass spectrometry. β-Propiolactone was shown to react with nine different amino acid residues. The most reactive residues are cysteine, methionine, and histidine and, to a lesser degree, aspartic acid, glutamic acid, tyrosine, lysine, serine, and threonine. Remarkably, cystine residues (disulfide groups) do not react with β-propiolactone. In addition, no reaction was observed for β-propiolactone with asparagine, glutamine, and tryptophan residues. β-Propiolactone modifies proteins to a larger extent than expected from current literature. In conclusion, the study determined the reactivity of β-propiolactone with nucleobase analogues, nucleosides, and amino acid residues and elucidated the chemical structures of the reaction products. The study provides detailed knowledge on the chemistry of β-propiolactone inactivation of viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868382      PMCID: PMC3196120          DOI: 10.1074/jbc.M111.279232

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  THE REACTION OF BETA-PROPIOLACTONE WITH GUANOSINE, DEOXYGUANYLIC ACID AND RNA.

Authors:  J J ROBERTS; G P WARWICK
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

2.  The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity.

Authors:  J R POLLEY; M M GUERIN
Journal:  Can J Microbiol       Date:  1957-10       Impact factor: 2.419

3.  The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions.

Authors:  J R POLLEY; M M GUERIN
Journal:  Can J Microbiol       Date:  1957-10       Impact factor: 2.419

4.  The activation of electrophile, nucleophile and leaving group during the reaction catalysed by pI258 arsenate reductase.

Authors:  Goedele Roos; Stefan Loverix; Elke Brosens; Karolien Van Belle; Lode Wyns; Paul Geerlings; Joris Messens
Journal:  Chembiochem       Date:  2006-06       Impact factor: 3.164

5.  The reaction of beta-propiolactone with derivatives of adenine and with DNA.

Authors:  R Chen; J J Mieyal; D A Goldthwait
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

6.  Identification of formaldehyde-induced modifications in proteins: reactions with model peptides.

Authors:  Bernard Metz; Gideon F A Kersten; Peter Hoogerhout; Humphrey F Brugghe; Hans A M Timmermans; Ad de Jong; Hugo Meiring; Jan ten Hove; Wim E Hennink; Daan J A Crommelin; Wim Jiskoot
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

7.  Reactivity-selectivity properties of reactions of carcinogenic electrophiles and nucleosides: influence of pH on site selectivity.

Authors:  T A Lyle; R E Royer; G H Daub; D L Vander Jagt
Journal:  Chem Biol Interact       Date:  1980-02       Impact factor: 5.192

8.  Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.

Authors:  A Scheidler; K Rokos; T Reuter; R Ebermann; G Pauli
Journal:  Biologicals       Date:  1998-06       Impact factor: 1.856

9.  Assessment of the propensity for covalent binding of electrophiles to biological substrates.

Authors:  R M Carlson
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

10.  Experiments on the carcinogenicity and reactivity of beta-propiolactone.

Authors:  C E SEARLE
Journal:  Br J Cancer       Date:  1961-12       Impact factor: 7.640

View more
  23 in total

1.  Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.

Authors:  Chen Fan; Xiaohua Ye; Zhiqiang Ku; Liangliang Kong; Qingwei Liu; Cong Xu; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Production of a Sindbis/Eastern Equine Encephalitis chimeric virus inactivated cell culture antigen.

Authors:  C H Goodman; B J Russell; J O Velez; J J Laven; D A Bagarozzi; J L Moon; K Bedi; B W Johnson
Journal:  J Virol Methods       Date:  2015-07-20       Impact factor: 2.014

3.  Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccine.

Authors:  Dale L Barnard; David M Belnap; Parastoo Azadi; Christian Heiss; D Scott Snyder; Susan C Bock; Thomas W Konowalchuk
Journal:  Heliyon       Date:  2022-07-06

4.  Development of an algorithm for production of inactivated arbovirus antigens in cell culture.

Authors:  C H Goodman; B J Russell; J O Velez; J J Laven; W L Nicholson; D A Bagarozzi; J L Moon; K Bedi; B W Johnson
Journal:  J Virol Methods       Date:  2014-08-04       Impact factor: 2.014

Review 5.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

6.  Surface modifications of influenza proteins upon virus inactivation by β-propiolactone.

Authors:  Yi-Min She; Keding Cheng; Aaron Farnsworth; Xuguang Li; Terry D Cyr
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

7.  Potential biotechnological capabilities of cultivable mycobiota from carwash effluents.

Authors:  Timothy Sibanda; Ramganesh Selvarajan; Memory Tekere; Hlengilizwe Nyoni; Stephen Meddows-Taylor
Journal:  Microbiologyopen       Date:  2017-07-17       Impact factor: 3.139

Review 8.  Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.

Authors:  Paul Löffler
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.